Wilmot Cancer Center Physician to Head International Group
Alok Khorana, M.D., Vice Chief of the Hematology/Oncology division at the James P. Wilmot Cancer Center, has been appointed Chairman of the Hemostasis and Malignancy Subcommittee of the International Society of Thrombosis and Haemostasis (ISTH). The appointment signifies Khorana’s growing reputation as a global authority on thrombosis and other blood disorders.
Founded in 1969, ISTH, with more than 3,000 members, is the leading worldwide organization dedicated to the advancement of understanding, prevention, diagnosis and treatment of thrombotic and bleeding disorders. Its mission remains the advancement of education and stimulation of research into thrombosis and hemostasis through meetings, peer-reviewed publications and expert committees on practical issues related to research methods and standards.
Subcommittee Chairmen may be reappointed annually by the ISTH for up to three years. In his new, leadership role, Khorana will be responsible for the Subcommittee's 2013 program of work, primarily the 2013 Scientific Subcommittee Meeting which will take place in conjunction with the 24th ISTH Congress in June in Amsterdam. Khorana is tasked with proposing educational topics and speakers for the session.
“The Wilmot Cancer Center is fortunate to have such a talented and internationally recognized authority like Dr. Khorana as resource for our patients,” said Jonathan Friedberg, M.D., acting director of the Wilmot Cancer Center. “His appointment as chair accurately reflects the great esteem in which he is held in the global community of scientists and physicians studying both benign and malignant blood disorders.”
Khorana, who is also an associate professor of Hematology/Oncology in the Department of Medicine, has been at the Cancer Center since coming to the University of Rochester Medical Center as a Fellow in Hematology/Oncology in 1999. He is a resident of Pittsford.